Asthma inhalers

This procedure concerns competition rules applied to asthma inhalers. It aims to ensure fair market practices and prevent monopolies, potentially leading to more affordable treatments for patients.

It affects pharmaceutical companies producing asthma inhalers and patients who rely on these medications. The outcome could influence pricing and availability of essential respiratory treatments.